Search Results - "WARFEL, Noel"
-
1
PIM kinase (and Akt) biology and signaling in tumors
Published in Pharmacology & therapeutics (Oxford) (01-07-2015)“…The initiation and progression of human cancer is frequently linked to the uncontrolled activation of survival kinases. Two such pro-survival kinases that are…”
Get full text
Journal Article -
2
Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia
Published in Antioxidants (06-04-2017)“…The importance of the tumor microenvironment for cancer progression and therapeutic resistance is an emerging focus of cancer biology. Hypoxia, or low oxygen,…”
Get full text
Journal Article -
3
Defining the mechanisms underlying cyclin dependent kinase control of HIF-1α
Published in Oncotarget (2022)Get full text
Journal Article -
4
p21WAF1 and tumourigenesis: 20 years after
Published in Current opinion in oncology (01-01-2013)“…PURPOSE OF REVIEWThis review provides an overview of the structure, regulation and physiological functions of p21, the product of the cyclin-dependent kinase…”
Get full text
Journal Article -
5
Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer
Published in Molecular cancer therapeutics (01-01-2021)“…Cancer progression and the onset of therapeutic resistance are often the results of uncontrolled activation of survival kinases. The proviral integration for…”
Get full text
Journal Article -
6
Targeting CDK4/6 to oppose hypoxia-mediated therapeutic resistance
Published in Cell cycle (Georgetown, Tex.) (03-07-2017)Get full text
Journal Article -
7
PIM kinases alter mitochondrial dynamics and chemosensitivity in lung cancer
Published in Oncogene (01-03-2020)“…Resistance to chemotherapy represents a major obstacle to the successful treatment of non-small-cell lung cancer (NSCLC). The goal of this study was to…”
Get full text
Journal Article -
8
Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase (PHLPP): A New Player in Cell Signaling
Published in The Journal of biological chemistry (03-02-2012)“…Precise balance between phosphorylation, catalyzed by protein kinases, and dephosphorylation, catalyzed by protein phosphatases, is essential for cellular…”
Get full text
Journal Article -
9
PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species
Published in Molecular cancer therapeutics (01-07-2016)“…Intratumoral hypoxia is a significant obstacle to the successful treatment of solid tumors, and it is highly correlated with metastasis, therapeutic…”
Get full text
Journal Article -
10
Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53
Published in Cancer research (Chicago, Ill.) (15-09-2015)“…The tumor-suppressor p53 prevents cancer development via initiating cell-cycle arrest, cell death, repair, or antiangiogenesis processes. Over 50% of human…”
Get full text
Journal Article -
11
Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents
Published in Clinical cancer research (01-01-2018)“…Patients develop resistance to antiangiogenic drugs, secondary to changes in the tumor microenvironment, including hypoxia. PIM kinases are prosurvival kinases…”
Get full text
Journal Article -
12
Targeting PIM Kinases to Improve the Efficacy of Immunotherapy
Published in Cells (Basel, Switzerland) (01-11-2022)“…The Proviral Integration site for Moloney murine leukemia virus (PIM) kinases is a family of serine/threonine kinases that regulates numerous signaling…”
Get full text
Journal Article -
13
CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth
Published in Cell cycle (Georgetown, Tex.) (01-12-2013)“…Hypoxia-inducible factor 1 (HIF-1) is a major mediator of tumor physiology, and its activation is correlated with tumor progression, metastasis, and…”
Get full text
Journal Article -
14
Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors
Published in Oncogene (12-08-2021)“…Angiogenesis is essential for the sustained growth of solid tumors. Hypoxia-inducible factor 1 (HIF-1) is a master regulator of angiogenesis and constitutive…”
Get full text
Journal Article -
15
PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer
Published in Oncogene (02-02-2024)“…Lipid droplets (LDs) are dynamic organelles with a neutral lipid core surrounded by a phospholipid monolayer. Solid tumors exhibit LD accumulation, and it is…”
Get full text
Journal Article -
16
Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase
Published in Molecular cancer therapeutics (01-12-2018)“…Cancer resistance to PI3K inhibitor therapy can be in part mediated by increases in the PIM1 kinase. However, the exact mechanism by which PIM kinase promotes…”
Get full text
Journal Article -
17
Digital image analysis using video microscopy of human-derived prostate cancer vs normal prostate organoids to assess migratory behavior on extracellular matrix proteins
Published in Frontiers in oncology (13-01-2023)“…The advent of perpetuating living organoids derived from patient tissue is a promising avenue for cancer research but is limited by difficulties with precise…”
Get full text
Journal Article -
18
Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28
Published in Cells (Basel, Switzerland) (16-03-2022)“…Proviral integration sites for Moloney murine leukemia virus (PIM) kinases are upregulated at the protein level in response to hypoxia and have multiple…”
Get full text
Journal Article -
19
PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion
Published in The Journal of cell biology (05-06-2023)“…Distinguishing key factors that drive the switch from indolent to invasive disease will make a significant impact on guiding the treatment of prostate cancer…”
Get full text
Journal Article -
20
Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo
Published in Clinical cancer research (01-09-2007)“…Purpose: The development of new cancer drugs is slow and costly. HIV protease inhibitors are Food and Drug Administration approved for HIV patients. Because…”
Get full text
Journal Article